Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New CDK inhibitors in early development at BMS

Aug. 1, 2002

Bristol-Myers Squibb researchers identify CDK-inhibitory semicarbazides

Aug. 1, 2002

Zonagen awarded SBIR grant for Progenta in breast cancer

Aug. 1, 2002

Xyotax enters phase III evaluation in ovarian cancer

July 31, 2002

DNA minor groove-binding antitumor agent with potential in refractory tumors

July 31, 2002

HDAC-inhibitory hydroxamates recently described in Roche patent

July 31, 2002

Liposomal TOP-53 may be associated with improved tolerance

July 31, 2002

SignalGene updates progress of SG-292

July 30, 2002

Clofarex enters trials in AML, ALL and solid tumors

July 30, 2002

Researchers at Aventis report the isolation and activity of klainetins

July 30, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...